Physician profile
Kristofer Muzzi
NPI 1194305599
$1,884.10
in general payments reported to CMS, 2019-2025
11 companies · $904 in 2025
The $904 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.71 · 2023: $434 · 2024: $465 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,803.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $638.27 | 2023-2025 | Lithovue, Accolade Sr, Rezum Generator |
| Janssen Biotech, INC. | $371.71 | 2024-2025 | Erleada, Akeega |
| Medtronic, INC. | $176.93 | 2025 | Interstim |
| Janssen Scientific Affairs, LLC | $165.53 | 2025 | Erleada |
| Stryker Corporation | $145.97 | 2024 | 1788 |
| Calyxo, INC. | $130.95 | 2025 | Cvac Aspiration System |
| Becton, Dickinson and Company | $80.71 | 2022 | |
| Abbvie INC. | $79.18 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $44.96 | 2023 | Calquence, Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $26.54 | 2025 | |
| Astellas Pharma US INC | $23.35 | 2023 | Xtandi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristofer Muzzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.